Viewing Study NCT01822951


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2025-12-25 @ 9:31 PM
Study NCT ID: NCT01822951
Status: WITHDRAWN
Last Update Posted: 2015-10-26
First Post: 2013-03-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)
Sponsor: Ever Neuro Pharma GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module